RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Free cash flow

AbbVie Inc.ABBV

Market cap
$417.4B
P/E ratio
SummaryFinancials
Period EndFree cash flow (Million USD)YoY (%)
Dec 31, 202417,832-19.17%
Dec 31, 202322,062-9.02%
Dec 31, 202224,248+10.27%
Dec 31, 202121,990+30.97%
Dec 31, 202016,790+31.46%
Dec 31, 201912,772-0.13%
Dec 31, 201812,789+35.61%
Dec 31, 20179,431+43.72%
Dec 31, 20166,562-6.30%
Dec 31, 20157,003+138.44%
Dec 31, 20142,937-49.15%
Dec 31, 20135,776

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)